CENTRE FOR COMMERCIALIZATION OF REGENERATIVE MEDICINE Trademark

Trademark Overview


On Friday, November 19, 2021, a trademark application was filed for CENTRE FOR COMMERCIALIZATION OF REGENERATIVE MEDICINE with the United States Patent and Trademark Office. The USPTO has given the CENTRE FOR COMMERCIALIZATION OF REGENERATIVE MEDICINE trademark a serial number of 79338773. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, July 21, 2023. This trademark is owned by Centre for Commercialization of Regenerative Medicine. The CENTRE FOR COMMERCIALIZATION OF REGENERATIVE MEDICINE trademark is filed in the Treatment & Processing of Materials Services, Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Cryopreservation services; custom manufacture of biotechnological products for therapeutic use in the diagnosis, treatment, mitigation or prevention of disease, disorder or abnormal physical state or their symptoms

Business planning; providing market intelligence services

Reviewing standards and practices to assure compliance with regulations related to the research, development, manufacture and sale of products in the health care and medical fields and the administration of health care services

Development of pharmaceutical preparations and medicines; pharmaceutical research and development; the research and development of biotechnological products for therapeutic use in the diagnosis, treatment, mitigation or prevention of disease, disorder or abnormal physical state or their symptoms; development of biotechnological products for therapeutic use in the diagnosis, treatment, mitigation or prevention of disease, disorder or abnormal physical state or their symptoms; providing medical and scientific research information in the field of clinical trials; clinical trials; genetic testing for scientific research purposes; genetic engineering; genetic testing for scientific research purposes
centre for commercialization of regenerative medicine

General Information


Serial Number79338773
Word MarkCENTRE FOR COMMERCIALIZATION OF REGENERATIVE MEDICINE
Filing DateFriday, November 19, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, July 21, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCryopreservation services; custom manufacture of biotechnological products for therapeutic use in the diagnosis, treatment, mitigation or prevention of disease, disorder or abnormal physical state or their symptoms
Goods and ServicesBusiness planning; providing market intelligence services
Goods and ServicesReviewing standards and practices to assure compliance with regulations related to the research, development, manufacture and sale of products in the health care and medical fields and the administration of health care services
Goods and ServicesDevelopment of pharmaceutical preparations and medicines; pharmaceutical research and development; the research and development of biotechnological products for therapeutic use in the diagnosis, treatment, mitigation or prevention of disease, disorder or abnormal physical state or their symptoms; development of biotechnological products for therapeutic use in the diagnosis, treatment, mitigation or prevention of disease, disorder or abnormal physical state or their symptoms; providing medical and scientific research information in the field of clinical trials; clinical trials; genetic testing for scientific research purposes; genetic engineering; genetic testing for scientific research purposes

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, April 22, 2022
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, April 22, 2022
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 22, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 22, 2022
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCentre for Commercialization of Regenerative Medicine
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCA

Trademark Events


Event DateEvent Description
Thursday, April 21, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, April 22, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 26, 2022APPLICATION FILING RECEIPT MAILED
Wednesday, August 31, 2022ASSIGNED TO EXAMINER
Wednesday, October 5, 2022NON-FINAL ACTION WRITTEN
Thursday, October 6, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, December 19, 2022REFUSAL PROCESSED BY MPU
Monday, December 19, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, January 9, 2023REFUSAL PROCESSED BY IB
Sunday, May 7, 2023NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, July 19, 2023ASSIGNED TO EXAMINER
Friday, July 21, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, July 21, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, July 21, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, September 27, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 27, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, July 22, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, July 22, 2024FINAL DISPOSITION NOTICE SENT TO IB
Sunday, August 11, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, October 16, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB